Table 1a.
Patient characteristics
| Variable | All patients (n= 47) | Pancreatic adenocarcinoma de novo (n= 10) | Pancreatic adenocarcinoma from IPMN (n= 10) | Non-invasive IPMN (n= 21) |
|---|---|---|---|---|
| Age | 70 (32, 83) | 70 (58, 83) | 71 (57, 78) | 71 (43, 78) |
| Gender (male) | 15 (32%) | 5 (50%) | 4 (40%) | 4 (19%) |
| BMI | 26 (18, 43) | 25 (18, 33) | 27 (21, 33) | 27 (19, 43) |
| CA 19-9 (U/ml) | 40 (1, 11841) | 408 (1, 6284) | 203 (1, 11841) | 21 (1, 60) |
| ASA class | ||||
| 2 | 15 (32%) | 3 (30%) | 1 (10%) | 10 (48%) |
| 3 | 27 (57%) | 6 (60%) | 6 (60%) | 10 (48%) |
| 4 | 5 (11%) | 1 (10%) | 3 (30%) | 1 (5%) |
| Diabetes | ||||
| Long standing | 11 (23%) | 2 (20%) | 4 (40%) | 4 (19%) |
| Recent onset | 6 (13%) | 2 (20%) | 1 (10%) | 2 (10%) |
| Insulin-dependant | 4 (9%) | 0 (0%) | 2 (20%) | 1 (5%) |
| Hypertension | 29 (62%) | 6 (60%) | 8 (80%) | 11 (52%) |
| CAD | 13 (28%) | 5 (50%) | 3 (30%) | 5 (24%) |
| COPD | 5 (11%) | 0 (0%) | 1 (10%) | 4 (19%) |
| ETOH | 26 (55%) | 4 (40%) | 6 (60%) | 12 (57%) |
| Pancreatitis | 11 (23%) | 1 (10%) | 2 (20%) | 7 (33%) |
| Length of follow up (y) | 1.9 (0.0, 4.9) | 0.8 (0.0, 2.8) | 1.3 (0.2, 3.9) | 2.5 (0.2, 4.9) |
The sample median (minimum, maximum) is given for numerical variables. Information was unavailable for the following variables: weight loss at surgery (n= 2), and CA 19-9 (n= 8).
IPMN, intraductal papillary mucinous neoplasms; BMI, body mass index; ASA, American Society of Anesthesia; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; ETOH, alcohol use.